CVS Health (CVS) Price Target Boosted by $1

With an annual dividend yield of 2.88%, CVS Health Corporation (NYSE:CVS) is included among the 12 Best Blue Chip Dividend Stocks to Buy Now.

CVS Health (CVS) Price Target Boosted by $1

America’s leading health solutions company, CVS Health Corporation (NYSE:CVS) provides advanced health care from pharmacy services and health plans to health and wellness.

On May 8, Wells Fargo analyst Stephen Baxter slightly raised the firm’s price target on CVS Health Corporation (NYSE:CVS) from $102 to $103, while maintaining an ‘Overweight’ rating on the shares. The target boost reflects an upside of over 13% from the current price levels.

Wells Fargo remains constructive on the healthcare firm’s recently reported Q1 results and sees potential for upward revisions through the rest of 2026, given the conservative stance on Health Care Benefits guidance. The analyst firm is raising estimates based on the net favorable PYD and stronger PCW performance.

CVS Health Corporation (NYSE:CVS) reported strong results for the first quarter on May 6, exceeding estimates in both earnings and revenue. Moreover, the company raised its full-year 2026 profit guidance to a range of $7.30 to $7.50 per share, up from $7 to $7.20 previously. CVS now projects its full-year total revenues to be at least $405 billion, while its cash flow from operations is expected to be at least $9.5 billion.

While we acknowledge the risk and potential of CVS as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than CVS and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 12 Best Electric Utility Stocks to Buy for the Data Center Power Surge and 10 Best Fortune 500 Stocks to Buy According to Analysts

Disclosure: None. Follow Insider Monkey on Google News.